Tangerang, Indonesia — 5–7 December 2025 — Genèse Labs took part in the 16th International Seminar and Workshop in Aesthetic Medicine (i-SWAM) at ICE BSD, closing its 2025 international congress programme.

• Participation in Indonesia’s largest aesthetic medicine congress and exhibition

• Almost 300 international experts across aesthetic medicine, plastic surgery and dermatology tracks

• Full portfolio presented, including the products launched in 2025

• Extending the Southeast Asian strategy following Bangkok (2024) and Ho Chi Minh City (2025)

Founded in 2006 as a gathering of Indonesian aesthetic physicians, i-SWAM has grown into one of Asia-Pacific’s leading aesthetic medicine congresses, organised by the International Society of Aesthetic Medicine (ISAM). It combines scientific sessions, cadaver dissection workshops and a major exhibition, connecting local practitioners with global brands.

As the closing event of the year, Genèse Labs presented its full portfolio, including every product launched in 2025: Proluma™ PDLLA, PLLA and RH Collagen, Réluma, the expanded RG Body Filler family, the Exoluma™ series and Exo-PDRN, and Exo-Mask for post-treatment care. A range spanning treatment through to aftercare drew strong interest from local practitioners.

The journey that began in Bangkok in 2024 and continued through Ho Chi Minh City to Indonesia in 2025 established Genèse Labs’ presence across Southeast Asia’s key markets. The portfolio and global network built over 2025 laid the foundation for the new launches and expanded regulatory registrations of 2026.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.